Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Gastrointestinal Manifestations of Yao Syndrome (NOD2-Associated Autoinflammatory Disease)
John A Damianos1, Avinash K Nehra2, Joseph A Murray3
1Mayo Clinic Division of Gastroenterology and Hepatology, Rochester, MN, USA. damianos.john@mayo.edu.
Background:
Yao syndrome (YAOS) is a NOD2-associated autoinflammatory disease characterized by periodic fevers, dermatitis, polyarthritis, swelling of the distal extremities, and gastrointestinal symptoms in patients with specific NOD2 variants. While gastrointestinal symptoms are a hallmark of the disease, little is known about specific symptoms and their underlying mechanisms.
Methods:
In this study, we identified 24 patients with YAOS from an institutional YAOS databse. We evaluated their presenting gastrointestinal symptoms at initial presentation via the validated Gastrointestinal Symptom Rating Scale questionnaire, which 14 participants filled out. We then systematically analyzed all gastrointestinal-relevant blood work, stool studies, imaging, endoscopies, and motility testing.
Results:
Gastrointestinal symptoms were reported by 100% of patients, with the most prominent symptom being bloating. Most of the workup including stool testing, gastrointestinal-related bloodwork, and endoscopic examinations with biopsies was normal. Abdominopelvic radiographs and cross-sectional imaging studies were most often normal, although an excessive stool burden was commonly identified. A minority of patients had associated diagnoses of collagenous gastritis, celiac disease, autoimmune-like enteropathy, or microscopic colitis. Gastric and colonic motility testing was normal in most patients; however, anorectal manometry with balloon expulsion testing was abnormal in 100% of tested patients. A minority of patients had hepatic steatosis or benign liver lesions.
Conclusions:
Gastrointestinal symptoms of YAOS are universal and severe, and symptoms may arise from both inflammatory and non-inflammatory mechanisms. Bloating and constipation may be driven by dyssynergic defecation.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Other Disorders of Digestive System
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastrointestinal Motility Disorders